- Home
- FLWS vs YMAB Comparison
FLWS vs YMAB Comparison
Compare FLWS & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- YMAB
- Stock Information
- Founded
- FLWS 1976
- YMAB 2015
- Country
- FLWS United States
- YMAB United States
- Employees
- FLWS N/A
- YMAB N/A
- Industry
- FLWS Other Specialty Stores
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- FLWS Consumer Discretionary
- YMAB Health Care
- Exchange
- FLWS Nasdaq
- YMAB Nasdaq
- Market Cap
- FLWS 347.1M
- YMAB 386.7M
- IPO Year
- FLWS 1999
- YMAB 2018
- Fundamental
- Price
- FLWS $5.25
- YMAB $8.61
- Analyst Decision
- FLWS Hold
- YMAB Buy
- Analyst Count
- FLWS 1
- YMAB 10
- Target Price
- FLWS $7.50
- YMAB $13.91
- AVG Volume (30 Days)
- FLWS 459.8K
- YMAB 874.6K
- Earning Date
- FLWS 10-30-2025
- YMAB 11-07-2025
- Dividend Yield
- FLWS N/A
- YMAB N/A
- EPS Growth
- FLWS N/A
- YMAB N/A
- EPS
- FLWS N/A
- YMAB N/A
- Revenue
- FLWS $1,685,658,000.00
- YMAB $85,385,000.00
- Revenue This Year
- FLWS N/A
- YMAB N/A
- Revenue Next Year
- FLWS $2.38
- YMAB $13.97
- P/E Ratio
- FLWS N/A
- YMAB N/A
- Revenue Growth
- FLWS N/A
- YMAB N/A
- 52 Week Low
- FLWS $3.86
- YMAB $3.55
- 52 Week High
- FLWS $9.24
- YMAB $16.11
- Technical
- Relative Strength Index (RSI)
- FLWS 45.20
- YMAB 81.21
- Support Level
- FLWS $4.84
- YMAB $8.50
- Resistance Level
- FLWS $5.52
- YMAB $8.56
- Average True Range (ATR)
- FLWS 0.29
- YMAB 0.02
- MACD
- FLWS 0.01
- YMAB -0.12
- Stochastic Oscillator
- FLWS 51.52
- YMAB 100.00
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.